Peng Zhou

Dr. Peng Zhou

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2023 in Brain Imaging and Behavior
Verified
Journal Article
Open access
PDF file
JLJunquan Liang
Junquan Liang
QYQiaoyun Yu
Qiaoyun Yu
YLYuchen Liu
Yuchen Liu
YQYidan Qiu
Yidan Qiu
RTRundong Tang
Rundong Tang
PZPeng Zhou
Peng Zhou
Background: Major depressive and social anxiety disorders have a high comorbidity rate and similar cognitive patterns. However, their unique and shared neuroanatomical characteristics have not been fully identified. Methods: Voxel-based morphometric studies comparing gray matter volume between patients with major depressive disorder/social anxiety disorder and healthy controls were searched using 4 electronic databases from the inception to March 2022. Stereotactic data were extracted and subsequently tested for convergence and differences using activation likelihood estimation. In addition, based on the result of the meta-analysis, behavioral analysis was performed to assess the functional roles of the regions affected by major depressive disorder and/or social anxiety disorder. Results: In total, 34 studies on major depressive disorder with 2873 participants, and 10 studies on social anxiety disorder with 1004 subjects were included. Gray matter volume conjunction analysis showed that the right parahippocampal gyrus region, especially the amygdala, was smaller in patients compared to healthy controls. The contrast analysis of major depressive disorder and social anxiety disorder revealed lower gray matter volume in the right lentiform nucleus and medial frontal gyrus in social anxiety disorder and lower gray matter volume in the left parahippocampal gyrus in major depressive disorder. Behavioral analysis showed that regions with lower gray matter volume in social anxiety disorder are strongly associated with negative emotional processes. Conclusions: The shared and unique patterns of gray matter volume abnormalities in patients with major depressive and social anxiety disorder may be linked to the underlying neuropathogenesis of these mental illnesses and provide potential biomarkers. PROSPERO registration number: CRD42021277546.

4 August 2022 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Open access
YFYanyan Feng
Yanyan Feng
GZGuihua Zhu
Guihua Zhu
RCRuiming Chen
Ruiming Chen
GSGuoao Shi
Guoao Shi
MPMin Peng
Min Peng
PZPeng Zhou
Peng Zhou
Depression is a chronic and recurrent disease without satisfactory treatment strategies. The therapeutic effect of acupuncture is well known in Traditional Chinese medicine (TCM) due to its unique non-pharmacological nature. Electroacupuncture (EA) for antidepressant therapy has been widely recognized and used in clinic. In this study, the lipopolysaccharide (LPS)-induced depression mice model was used to evaluate the anti-depressant effects of EA treatment. Open Field Test (OFT), Force Swimming Test (FST), and Sucrose Preference Test (SPT) were utilized to detect the ethological alterations in mice. The transcriptology technique was used to evaluate the changes in the hippocampal transcriptome in different groups. We measured protein levels using Western blot and immunohistochemistry. Our data showed that LPS induced ethological alterations in mice and enhanced the gene expression related to gene ontology such as the banded collagen fibril, fibrillar collagen trimer, and collagen fibril organization, pathways such as collagen chain trimerization, collagen biosynthesis and modifying enzymes, and collagen formation. EA could reverse the ECM deposition by inhibiting collagen type Ⅳ trimer, extracellular matrix organization, and collagen formation. EA could enhance the MMP1 and MMP9 expression and promote synaptic plasticity. These data indicated that EA possesses an antidepressant effect, this may achieve by increasing MMPs expression and then remodeling the ECM surrounding the neurons, ultimately repairing neural circuits and promoting synaptic plasticity.

10 November 2022 in Human Cell
Verified
Journal Article
Closed access
PDF file
WLWeihan Li
Weihan Li
CYChaojie Yang
Chaojie Yang
JLJingjing Li
Jingjing Li
XLXiaolian Li
Xiaolian Li
PZPeng Zhou
Peng Zhou

10 October 2024 in Brain Imaging and Behavior
Verified
Journal Article
Open access
PDF file
JLJunquan Liang
Junquan Liang
QYQiaoyun Yu
Qiaoyun Yu
LCLimei Chen
Limei Chen
ZLZhongxian Li
Zhongxian Li
YLYuchen Liu
Yuchen Liu
PZPeng Zhou
Peng Zhou
Chronic obstructive pulmonary disease (COPD) is frequently comorbid with cognitive impairment, but it has not been paid enough attention, and its neuroanatomical characteristics have not been fully identified. Voxel-based morphometric (VBM) studies comparing gray matter (GM) abnormalities in COPD patients with healthy controls (HCs) were searched using 8 electronic databases from the inception to March 2023. Stereotactic data were extracted and tested for convergence and differences using the activation likelihood estimation (ALE) method. Moreover, based on the ALE results, a structural meta-analytic connectivity modeling (MACM) was conducted to explore the co-atrophy pattern in patients with COPD. Last, behavioral analysis was performed to assess the functional roles of the regions affected by COPD. In total, 11 studies on COPD with 949 participants were included. Voxel-based meta-analysis revealed significant GM abnormalities in the right postcentral gyrus (including inferior parietal lobule), left precentral gyrus, and left cingulate gyrus (including paracentral lobule) in patients with COPD compared with HCs. Further MACM analysis revealed a deeper co-atrophy pattern between the brain regions with abnormal GM structure and the insula in COPD patients. Behavioral analysis showed that the abnormal GM structure in the left cingulate gyrus (including paracentral lobule) was strongly associated with cognitive function, especially executive function. COPD comorbid with cognitive impairment has a specific neurostructural basis of GM structural abnormalities, which may also involve a deeper co-atrophy pattern between the insula. These findings enhance our understanding of the underlying neuropathogenesis and suggest potential imaging markers for cognitive impairment in COPD patients. PROSPERO registration number: CRD42022298722.

30 June 2023 in Medicine
Verified
Journal Article
Open access
XZXiayun Zhou
Xiayun Zhou
FLFei Mm Luo
Fei Mm Luo
GSGuoao Mm Shi
Guoao Mm Shi
RCRuiming Mm Chen
Ruiming Mm Chen
PZPeng Zhou
Peng Zhou
Background: Macrophages are closely related to the occurrence and development of depression, but there are few bibliometric studies on the role of macrophages in depression. We aim to examine the current state and frontier trends of the research on macrophages in depression from 2000 to 2022 in this study, so as to establish a new direction for follow-up research. Methods: The literature scan covering the period 2000 to 2022 was performed on macrophages in depression, which were analyzed with Citespace 6.1.R2 and VOSviewer 1.6.18 after manual screening, including country publications, institutions, authors, journals, keywords, and references. Results: This study included 387 papers in total. There has been an increase in the number of published papers since 2009. In terms of productivity, the United States and Ohio State University are the most productive countries and institutions. The most cited author is Maes M, cited 173 times, which has made a great contribution to the study of macrophages in depression. In terms of publications, Pariante CM, Drexhage HA. have the largest number, each author with five. Brain Behavior and Immunity is the most published and cited journals. The highest burst intensity keyword is microglia, and the highest burst intensity reference is Dowlati Y, 2010. Conclusion: Research hotspots and trends are analyzed and predicted in this study, which will facilitate the development of macrophage research in depression, so as to provide a reference for further research in this field.

1 January 2024 in Brazilian Journal of Medical and Biological Research
Verified
Journal Article
Open access
PDF file
XZXiayun Zhou
Xiayun Zhou
GSGuoao Shi
Guoao Shi
RCRuiming Chen
Ruiming Chen
LHLingsan Hu
Lingsan Hu
ZLZhongxian Li
Zhongxian Li
PZPeng Zhou
Peng Zhou
During the COVID-19 outbreak, there was a sharp increase in generalized anxiety disorder (GAD). Acupuncture therapy has the advantages of accurate clinical efficacy, safety and reliability, few adverse reactions, and no dependence, and is gradually becoming one of the emerging therapies for treating GAD. We present a study protocol for a randomized clinical trial with the aim of exploring the mechanism of brain plasticity in patients with GAD and evaluate the effectiveness and reliability of acupuncture treatment. Transcranial magnetic stimulation (TMS) will be used to assess cortical excitability in GAD patients and healthy people. Sixty-six GAD patients meeting the inclusion criteria will be randomly divided into two groups: TA group, (treatment with acupuncture and basic western medicine treatment) and SA group (sham acupuncture and basic western medicine treatment). Twenty healthy people will be recruited as the control group (HC). The parameters that will be evaluated are amplitude of motor evoked potentials (MEPs), cortical resting period (CSP), resting motor threshold (RMT), and Hamilton Anxiety Scale (HAMA) score. Secondary results will include blood analysis of γ-aminobutyric acid (GABA), glutamate (Glu), glutamine (Gln), serotonin (5-HT), and brain-derived nerve growth factor (BDNF). Outcomes will be assessed at baseline and after the intervention (week 8). This study protocol is the first clinical trial designed to detect differences in cerebral cortical excitability between healthy subjects and patients with GAD, and the comparison of clinical efficacy and reliability before and after acupuncture intervention is also one of the main contents of the protocol. We hope to find a suitable non-pharmacological alternative treatment for patients with GAD.